etherna, an mRNA/LNP technologies company, has announced that Bernard Sagaert has been confirmed as Chief Executive Officer. At the same time Marijn Dekkers, an existing Board Member representing investor Novalis LifeSciences LLC, has been appointed Chairman of the Board. Sagaert’s appointment follows an interim 12-month period during which he has successfully led the company’s pivot […]
